ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
207.88
-1.55 (-0.74%)
May 5, 2026, 4:00 PM EDT - Market closed
ResMed Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 5,538 | 5,146 | 4,685 | 4,223 | 3,578 | 3,197 | |
Revenue Growth (YoY) | 10.28% | 9.84% | 10.95% | 18.02% | 11.93% | 8.11% |
Cost of Revenue | 2,127 | 2,091 | 2,030 | 1,867 | 1,554 | 1,358 |
Gross Profit | 3,411 | 3,055 | 2,655 | 2,356 | 2,024 | 1,839 |
Selling, General & Admin | 1,088 | 991.02 | 917.14 | 874 | 737.51 | 670.39 |
Depreciation & Amortization Expenses | 46.9 | 45.27 | 46.52 | 42.02 | 31.08 | 31.08 |
Research & Development | 359 | 331.28 | 307.53 | 287.64 | 253.58 | 225.28 |
Other Operating Expenses | 25.81 | 2.03 | 64.23 | 20.13 | 1.86 | 8.67 |
Total Operating Expenses | 1,520 | 1,370 | 1,335 | 1,224 | 1,024 | 935.42 |
Operating Income | 1,893 | 1,685 | 1,320 | 1,132 | 1,000 | 903.68 |
Interest Income | 22.23 | -2.54 | -51.6 | -44.72 | -43 | -20.32 |
Other Non-Operating Income (Expense) | -11.47 | -5.26 | -3.49 | 14.52 | 3.2 | 0.3 |
Total Non-Operating Income (Expense) | 10.76 | -7.8 | -55.1 | -30.21 | -39.8 | -20.02 |
Pretax Income | 1,903 | 1,678 | 1,265 | 1,102 | 960.48 | 883.66 |
Provision for Income Taxes | 383.74 | 276.84 | 243.85 | 204.11 | 181.05 | 409.16 |
Net Income | 1,520 | 1,401 | 1,021 | 897.56 | 779.44 | 474.51 |
Net Income to Common | 1,520 | 1,401 | 1,021 | 897.56 | 779.44 | 474.51 |
Net Income Growth | 15.71% | 37.20% | 13.75% | 15.15% | 64.26% | -23.67% |
Shares Outstanding (Basic) | 146 | 147 | 147 | 147 | 146 | 145 |
Shares Outstanding (Diluted) | 147 | 147 | 148 | 147 | 147 | 146 |
Shares Change (YoY) | -0.64% | -0.14% | 0.06% | 0.28% | 0.40% | 0.55% |
EPS (Basic) | 10.40 | 9.55 | 6.94 | 6.12 | 5.34 | 3.27 |
EPS (Diluted) | 10.37 | 9.51 | 6.92 | 6.09 | 5.30 | 3.24 |
EPS Growth | 16.39% | 37.43% | 13.63% | 14.91% | 63.58% | -24.12% |
Shares Outstanding | 145.04 | 146.39 | 146.9 | 147.06 | 146.41 | 145.65 |
Free Cash Flow | 1,754 | 1,662 | 1,302 | 573.63 | 216.31 | 634.01 |
Free Cash Flow Growth | 5.57% | 27.65% | 126.94% | 165.19% | -65.88% | -10.32% |
Free Cash Flow Per Share | 11.97 | 11.28 | 8.82 | 3.89 | 1.47 | 4.33 |
Dividends Per Share | 2.330 | 2.120 | 1.920 | 1.760 | 1.680 | 1.590 |
Dividend Growth | 9.91% | 10.42% | 9.09% | 4.76% | 5.66% | 1.92% |
Gross Margin | 61.59% | 59.36% | 56.67% | 55.78% | 56.57% | 57.53% |
Operating Margin | 34.18% | 32.75% | 28.17% | 26.80% | 27.96% | 28.27% |
Profit Margin | 27.44% | 27.22% | 21.79% | 21.25% | 21.78% | 14.84% |
FCF Margin | 31.68% | 32.29% | 27.78% | 13.58% | 6.05% | 19.83% |
EBITDA | 2,156 | 1,921 | 1,536 | 1,329 | 1,194 | 1,095 |
EBITDA Margin | 38.93% | 37.33% | 32.79% | 31.48% | 33.37% | 34.26% |
EBIT | 1,893 | 1,685 | 1,320 | 1,132 | 1,000 | 903.68 |
EBIT Margin | 34.18% | 32.75% | 28.17% | 26.80% | 27.96% | 28.27% |
Effective Tax Rate | 20.16% | 16.50% | 19.28% | 18.53% | 18.85% | 46.30% |
Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.